MAPT and Alzheimer disease: To assess whether these brains exhibited other early- or late-stage p-Tau markers, we examined two additional phosphorylated tau proteins: CP13, associated with early (pre-tangle) AD pathology, and PHF1, which appears at later stages of cognitive decline of AD [51].